Mostrando 173,401 - 173,420 Resultados de 174,586 Para Buscar '"'39"', tiempo de consulta: 1.68s Limitar resultados
  1. 173401
    “…The operation time and fluoroscopy times were 85.79 ± 12.90 min and 39.05 ± 4.59 times, respectively. The fluoroscopy times (frequency) for L4/5 and L5/S1 were 26.95 ± 6.41 and 12.11 ± 3.49 (t = 7.00, P < 0.05). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 173402
    “…METHODS: A cross-sectional study was conducted from 26 October to 6 November 2018 in Yambio County, South Sudan among 630 children aged 6–59 months from the 348 households surveyed in 39 clusters using two-stage cluster sampling design. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 173403
    “…RESULTS: There were no statistically significant differences between the groups for the heiQ domains (adjusted mean difference [Txt2Prevent minus usual care] for each domain—Health-directed activity: –0.13, 95% CI –0.39 to 0.13, P=.31; Positive and active engagement in life: 0.03, 95% CI –0.19 to 0.25, P=.76; Emotional distress: 0.04, 95% CI –0.22 to 0.29, P=.77; Self-monitoring and insight: –0.14, 95% CI –0.33 to 0.05, P=.15; Constructive attitudes and approaches: –0.10, 95% CI –0.36 to 0.17, P=.47; Skill technique and acquisition: 0.05, 95% CI –0.18 to 0.27, P=.69; Social integration and support: –0.12, 95% CI –0.34 to 0.10, P=.27; and Health services navigation: –0.05, 95% CI –0.29 to 0.19, P=.69). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 173404
  5. 173405
    “…At univariable analysis, both hs-cTnT and NT-pro BNP significantly correlated with native T1 and T2 in groups with eGFR 30–59 ml/min/1.73 m(2) and eGFR < 29 ml/min/1.73 m(2) groups, with associations being stronger at lower eGFR (NT-pro BNP (log transformed, lg10): native T1 r = 0.43 and r = 0.57, native T2 r = 0.39 and r = 0.48 respectively; log-transformed hs-cTnT(lg10): native T1 r = 0.23 and r = 0.43, native T2 r = 0.38 and r = 0.58 respectively, p < 0.001 for all, p < 0.05 for interaction). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 173406
    “…Les 6 concepts de santé mentale majoritaires détectés sont la colère (39,8 %) la dépression (19,8 %), l’anxiété (18,9 %), la peur (12,1 %), le stress (7,4 %) et des troubles du sommeil (2,0 %). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 173407
    por Ovadia, Caroline, Sajous, Jenna, Seed, Paul T, Patel, Kajol, Williamson, Nicholas J, Attilakos, George, Azzaroli, Francesco, Bacq, Yannick, Batsry, Linoy, Broom, Kelsey, Brun-Furrer, Romana, Bull, Laura, Chambers, Jenny, Cui, Yue, Ding, Min, Dixon, Peter H, Estiú, Maria C, Gardiner, Fergus W, Geenes, Victoria, Grymowicz, Monika, Günaydin, Berrin, Hague, William M, Haslinger, Christian, Hu, Yayi, Indraccolo, Ugo, Juusela, Alexander, Kane, Stefan C, Kebapcilar, Ayse, Kebapcilar, Levent, Kohari, Katherine, Kondrackienė, Jūratė, Koster, Maria P H, Lee, Richard H, Liu, Xiaohua, Locatelli, Anna, Macias, Rocio I R, Madazli, Riza, Majewska, Agata, Maksym, Kasia, Marathe, Jessica A, Morton, Adam, Oudijk, Martijn A, Öztekin, Deniz, Peek, Michael J, Shennan, Andrew H, Tribe, Rachel M, Tripodi, Valeria, Türk Özterlemez, Naciye, Vasavan, Tharni, Wong, L F Audris, Yinon, Yoav, Zhang, Qianwen, Zloto, Keren, Marschall, Hanns-Ulrich, Thornton, Jim, Chappell, Lucy C, Williamson, Catherine
    Publicado 2021
    “…Ursodeoxycholic acid treatment had no effect on the prevalence of the composite outcome in all studies (aOR 1·28, 95% CI 0·86–1·91; p=0·22), but was associated with a reduced composite outcome when considering only randomised controlled trials (0·60, 0·39–0·91; p=0·016). INTERPRETATION: Ursodeoxycholic acid treatment had no significant effect on the prevalence of stillbirth in women with intrahepatic cholestasis of pregnancy, but our analysis was probably limited by the low overall event rate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 173408
    por Atkinson, Andrew, Miro, Jose M., Mocroft, Amanda, Reiss, Peter, Kirk, Ole, Morlat, Philippe, Ghosn, Jade, Stephan, Christoph, Mussini, Cristina, Antoniadou, Anastasia, Doerholt, Katja, Girardi, Enrico, De Wit, Stéphane, Kraus, David, Zwahlen, Marcel, Furrer, Hansjakob, Antoniadou, A., Castagna, A, Doerholt, K, Fätkenheuer, G, Raben, D, Teira, R, Zangerle, R, Judd, Ali, Zangerle, Robert, Touloumi, Giota, Warszawski, Josiane, Meyer, Laurence, Dabis, François, Krause, Murielle Mary, Leport, Catherine, Wittkop, Linda, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Fätkenheuer, Gerd, Del Amo, Julia, Obel, Niels, Thorne, Claire, Pérez‐Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Noguera‐Julian, Antoni, Antinori, Andrea, d’Arminio Monforte, Antonella, Brockmeyer, Norbert, Prieto, Luis, Conejo, Pablo Rojo, Soriano‐Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Casabona, Jordi, Castagna, Antonella, Goetghebuer, Tessa, Sönnerborg, Anders, Torti, Carlo, Sabin, Caroline, Teira, Ramon, Garrido, Myriam, Haerry, David, Costagliola, Dominique, d’Arminio‐Monforte, Antonella, Castagna, Antonella, del Amo, Julia, Raben, Dorthe, Chêne, Geneviève, Judd, Ali, Conejo, Pablo Rojo, Barger, Diana, Schwimmer, Christine, Termote, Monique, Wittkop, Linda, Frederiksen, Casper M, Raben, Dorthe, Brandt, Rikke Salbøl, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Bucher, Heiner, Cozzi‐Lepri, Alessandro, Dabis, François, d’Arminio Monforte, Antonella, Davies, Mary‐Anne, del Amo, Julia, Dorrucci, Maria, Dunn, David, Egger, Matthias, Guiguet, Marguerite, Grabar, Sophie, Judd, Ali, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Meyer, Laurence, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Phillips, Andrew, Puoti, Massimo, Rohner, Eliane, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, Thorne, Claire, Torti, Carlo, van der Valk, Marc, Wittkop, Linda
    Publicado 2021
    “…For patients off prophylaxis with CD4 counts between 100 and 200 cells/µL and HIV‐RNA below 400 copies/mL, the incidence of recurrent PjP was 3.9 (95% CI: 2.0 to 5.8) per 1000 py, not significantly different from patients on prophylaxis in the same stratum (1.9, 95% CI: 0.1 to 3.7). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 173409
    “…Overall, the Pilates group (PG) had a significantly greater reduction in post-prandial blood glucose than the control group (CG) (MD = −22.25 mg/dL, 95% CI: [−28.34, 16.17] mg/dL, P < 0.00001, I(2) = 0%); glycated hemoglobin (HbA1c) (MD = −0.78%, 95% CI: [−1.13, −0.42]%, P < 0.0001, I(2) = 88%); total cholesterol (TC) (MD = −20.90 mg/dL, 95% CI: [−37.21, −4.60] mg/dL, P = 0.01, I(2) = 84%); triglycerides (TG) (MD = −12.59 mg/dL, 95% CI: [−19.88, −5.29] mg/dL, P = 0.0007, I(2) = 86%); and low density lipoprotein cholesterol (LDL-C) (MD = −12.39 mg/dL, 95% CI: [−16.82, −7.95] mg/dL, P < 0.00001, I(2) = 45%) compared to CG, whereas no significant difference was detected between the two groups in fasting blood glucose (MD = −7.04 mg/dL, 95% CI: [−17.26, 3.17] mg/dL, P = 0.18, I(2) = 93%), insulin (MD = −1.44 μU/mL, 95% CI: [−4.30, 1.41] μU/mL, P = 0.32, I(2) = 0%); and high density lipoprotein cholesterol (HDL-C) (MD = −2.68 mg/dL, 95% CI: [−9.03, 3.67] mg/dL, P = 0.41, I(2) = 89%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 173410
    “…Using data from the Ontario Cancer Registry, we identified all women 15–39 years of age diagnosed with the most common cancers in AYAs (brain, breast, colorectal, leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, thyroid and melanoma) from 1992 to 2011 who lived at least 5 years recurrence-free (Exposed, n = 14,316). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 173411
    “…The TGD group also had higher symptom scores (CES-D mean difference: 7.69; 95% CI, 3.30 to 12.08; P < .001; MASC mean difference: 7.56; 95% CI, 0.46 to 14.66; P = .04; and DERS mean difference: 18.43; 95% CI, 8.39 to 28.47; P < .001). Symptom scores were significantly higher at entry vs discharge (CES-D mean difference, −12.16; 95% CI, −14.50 to −9.80; P < .001; MASC mean difference: −3.79; 95% CI, −6.16 to −1.42; P = .02; and DERS mean difference: −6.37; 95% CI, −10.80 to −1.94; P = .05) and follow-up (CES-D mean difference: −9.69; 95% CI, −13.0 to −6.42; P < .001; MASC mean difference: −6.92; 95% CI, −10.25 to −3.59; P < .001; and DERS mean difference: −12.47; 95% CI, −18.68 to −6.26; P < .001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 173412
    por Pérez-Latorre, Leire, Berenguer, Juan, Micán, Rafael, Montero, Marta, Cifuentes, Carmen, Puig, Teresa, Sanz, José, Ferrero, Oscar L, De La Fuente, Belén, Rodríguez, Carmen, Reus, Sergio, Hernández-Quero, José, Gaspar, Gabriel, Pérez-Martínez, Laura, García, Coral, Force, Luis, Veloso, Sergio, De Miguel, Marta, Jarrín, Inmaculada, González-García, Juan, Fanciulli, C, Miralles, P, López, JC, Parras, F, Padilla, B, Aldámiz-Echevarría, T, Carrero, A, Díez, C, Tejerina, F, Berenguer, J, Hontañón, V, Busca, C, Delgado, A, Arnalich, F, Arribas, JR, Bernardino, JI, De Miguel, R, Martín-Carbonero, ML, Montejano, R, Montes, ML, Moreno, V, Pérez-Valero, I, Valencia, E, Vivancos, MJ, Moreno, S, Moreno, A, Casado, JL, Pérez-Elías, MJ, Quereda, C, Domínguez, L, Hernando, A, Bisbal, O, De Lagarde, M, Matarranz, M, Rubio, R, Pulido, F, Navarro, J, Torrella, A, Ramos, N, Rodrigo, M, Estrada, V, Vergas, J, Téllez, MJ, Muñoz, J, Gutiérrez, M, Mateo, G, Guardiola, JM, Ibarguren, M, Carmona, MP, Rodríguez-Arrondo, F, Goenaga, MA, Azkune, H, Von Wichmann, MA, Iribarren, JA, Brieva, T, Camacho, A, Machuca, IM, Rivero-Juárez, A, Rivero-Román, A, Ruiz, J, Nuño, E, Palacios, R, Santos, J, Márquez, M, Carmena, J, Artero, A, Morano, L, Crespo, M, García, L, Otero, S, Sanz, J, Santos, I, Moreno, J, Arazo, P, Armiñanzas, C, Echevarría, S, Gutiérrez-Cuadra, M, Fariñas, MC, Ferrer, A, Galindo, MJ, Tasias, M, Cuellar, S, Calabuig, E, Blanes, M, Fernández, J, López-Aldeguer, J, Salavert, M, Domingo, P, de Miguel, J, Arranz, A, Casas, E, Ferrero, OL, Ibarra, S, López, I, de la Peña, M, Zubero, Z, Baraia, J, Muñoz, J, Campoamor, M, Tuya, MJ, Rodríguez, C, Puerta, T, Raposo, M, Vera, M, Del Romero, J, Reus, S, Giner, L, Merino, E, Boix, V, Torrús, D, Portilla, I, Pampliega, M, Díez, M, Egea, I, Portilla, J, Vinuesa, D, Muñoz, L, García, L, Oteo, JA, García, C, Barrufet, P, Peraire, J, Viladés, C, Vargas, M, Castellano, A, Vidal, F, Velasco, M, Moreno, L, Hervás, R, Losa, JE, Vilaró, J, Cano, A, Alcaráz, A, Muñoz, A, Bernal, E, Gimeno, A, Montero, C, Arponen, S, Orti, AJ, Chamarro, E, Escrig, C, Chocarro, A, Teira, R, Alonso, G, Toledo, C, Peláez, AI, Lara, G, Fernández, I, Esteban, MC, Gómez-Alfaro, E, Silvariño, R, Vegas, A, Geijo, P, Bisbe, J
    Publicado 2021
    “…The prevalence in 2002, 2009, 2015, 2016 and 2017 was 4.9%, 3.4%, 3%, 3.9% and 3%, respectively. Among the HIV/HBV-coinfected patients identified in 2018, 16.7% had cirrhosis according to transient elastography and 26.3% tested positive for antibodies against hepatitis D virus. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 173413
  14. 173414
    “…MRI mediated the association between [(18)F]flortaucipir PET and MMSE in the groups with AD dementia (33.4% [95% CI, 15.5%-60.0%] of the total effect) and Aβ-positive MCI (13.6% [95% CI, 0.0%-28.0%] of the total effect), but not the Aβ-positive CU group (3.7% [95% CI, −17.5% to 39.0%]; P = .71). Age (t = −2.28; P = .02), but not sex (t = 0.92; P = .36) or APOE genotype (t = 1.06; P = .29) modified the association between baseline [(18)F]flortaucipir PET and cognitive change, such that older individuals showed faster cognitive decline at similar tau PET levels. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 173415
    “…Pre-existing comorbidities associated with severe disease were diabetes (135 [31·3%] of 431 with vs 868 [16·0%] of 5421 without; crude OR 4·38 [2·58–7·43]), hypertension (240 [35·0%] of 685 vs 763 [20·6%] of 3695; 2·19 [1·36–3·53]), renal disease (44 [45·8%] of 96 vs 271 [16·0%] of 1690; 4·67 [2·21–9·88]), and cardiovascular disease (nine [23·1%] of 39 vs 155 [8·6%] of 1793; 2·79 [1·04–7·50]). Clinical features during the febrile phase associated with progression to severe disease were vomiting (329 [13·5%] of 2432 with vs 258 [6·8%] of 3797 without; 2·25 [1·87–2·71]), abdominal pain and tenderness (321 [17·7%] of 1814 vs 435 [8·1%] of 5357; 1·92 [1·35–2·74]), spontaneous or mucosal bleeding (147 [17·9%] of 822 vs 676 [10·8%] of 6235; 1·57 [1·13–2·19]), and the presence of clinical fluid accumulation (40 [42·1%] of 95 vs 212 [14·9%] of 1425; 4·61 [2·29–9·26]). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 173416
    “…The expression of 18 selected miRNAs (cel-miR-39 and cel-miR-54 as spike-in controls, hsa-miR-16-5p and hsa-miR-25-3p as endogenous controls, hsa-miR-17-5p, hsa-miR-18a-5p, hsa-miR-30a-3p, hsa-miR-30c-5p, hsa-miR-126-3p, hsa-miR-133a-3p, hsa-miR-142-3p, hsa-miR-143-3p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-222-3p, hsa-miR-223-3p, hsa-miR-488-3p and hsa-miR-920) was measured using qPCR. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 173417
    “…In addition, operation time (OP), blood loss (BL), and hospital stay (HS) in the simultaneous operation group were 245.00 ± 5.00 min, 480.00 ± 27.39 mL, and 16.60 ± 0.55 days, respectively. While those parameters in the first cervical surgery group were 342.50 ± 18.18 min, 528.21 ± 43.97 mL, and 22.75 ± 2.15 days, and in the first lumbar surgery group they were 346.11 ± 24.77 min, 519.44 ± 43.99 mL, and 22.89 ± 1.64 days. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 173418
    “…There were significant reductions between the intervention and control groups in the primary trial outcome, mean energy (kilojoules) content of discretionary foods packed in lunchboxes (–117.26 kJ; 95% CI –195.59 to –39.83; P=.003). Relative to the control, the intervention also significantly reduced secondary outcomes regarding the mean total lunchbox energy (kilojoules) packed (–88.38 kJ; 95% CI –172.84 to –3.92; P=.04) and consumed (–117.17 kJ; 95% CI –233.72 to –0.62; P=.05). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 173419
    por Shi, Ping, Liu, Aimin, Yin, Xiaoyan
    Publicado 2021
    “…While rates of GWG below IOM guidelines in both second and third trimesters of pregnancy was associated with a decreased odds of macrosomia (aOR = 0.66, 95% CI: 0.52–0.78; aOR = 0.52, 0.39–0.63) and LGA(aOR = 0.71, 0.51–0.82; aOR = 0.67, 0.55–0.79). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 173420
    “…As identified from the undersurface of the everted extensor mechanism, it was found to insert a mean distance of 10.5 mm (range 3.9 – 18.2) from the superior pole of the patella. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS